doi: 10.3109/07357900903287048 219 SchallyAVVargaJL
In the ever-evolving healthcare landscape, pharmaceutical advancements continue redefining how we approach various health conditions
As for mortality, both SGLT-2 inhibitors and GLP-1RA are similar in reducing both total and CV deaths, but SGLT-2 inhibitors only are superior to DPP-4 inhibitors for both deaths, whereas GLP-1RA are superior to DPP-4 inhibitors for total death, but equal for CV death
We will help you figure out what is driving the change and what your options are.
The Endocrine Society's 2023 clinical practice guideline on pharmacologic management of obesity notes that GLP-1 receptor agonists may affect oral drug absorption but emphasizes that "clinically significant reductions in efficacy have not been demonstrated for most co-administered medications" [7]
Its really about being proactive and treating early to maintain the skins tone and elasticity before sagging becomes more difficult to address